CPT code 0264U: Genome mapping, structural variant detection2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Optical genome mapping identifies structural DNA abnormalities associated with rare heritable disorders, including copy-number changes and rearrangements.
Medicare pays $1,263.53 for 0264U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$1,263.53
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 0264U covers
0264U identifies structural abnormalities associated with rare heritable disorders using optical genome mapping. The targeted findings include copy-number variations, inversions, insertions, translocations, and other structural variants. These are changes in genome structure assessed through optical mapping. This service is distinct from a code describing optical mapping combined with sequencing, which is reported when that combined assay is performed.
Report 0264U for the optical genome-mapping assay performed. Medicare pays the code only under the CLFS, at one nationally set amount applicable across states and localities, with no geographic or office/facility adjustment. The 2026 national CLFS amount is $1,263.53, unchanged from 2023 through 2026. No separate physician fee schedule payment is assigned to 0264U.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0264U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0264U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0264U: Medicare pays the test only from the CLFS.
0264U on the lab fee schedule since 2021
0264U · CLFS 2026 Q4 (current)
$1,263.53
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $1,263.53
21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.
0264U compared with similar tests
- 0260UGenome mappingStructural variant detection$1,263.53
- 0260U is also identified as a rare-disease optical genome-mapping code. Select the code that corresponds to the assay represented.
- 0267UGenome testMapping plus sequencing$6,739.33
- 0267U describes optical genome mapping combined with sequencing; 0264U describes optical genome mapping.
- 0265UGenome sequencingRare heritable disorders$5,475.80
- 0265U uses whole-genome and mitochondrial DNA sequencing, rather than optical genome mapping.
0264U billing questions
What structural findings does 0264U identify?
It identifies abnormalities associated with rare heritable disorders, including copy-number variations, inversions, insertions, translocations, and other structural variants.
How does 0264U differ from 0267U?
0264U describes optical genome mapping. 0267U describes rare-disease identification using optical genome mapping combined with sequencing.
How does 0264U differ from 0265U?
0264U uses optical genome mapping to identify structural abnormalities. 0265U describes rare-disease testing using whole-genome and mitochondrial DNA sequencing.
Does 0264U have a separate physician interpretation payment?
No separate physician fee schedule payment is assigned to 0264U; Medicare pays the code under the CLFS.
Does Medicare payment for 0264U vary by locality?
No. The CLFS amount is national and applies across states and localities without geographic or office/facility adjustment.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0264U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist